98%
921
2 minutes
20
Microhomology-mediated break-induced replication (MMBIR) is a DNA repair pathway initiated by polymerase template switching at microhomology, which can produce templated insertions that initiate chromosomal rearrangements leading to neurological and metabolic diseases, and promote complex genomic rearrangements (CGRs) found in cancer. Yet, how often templated insertions accumulate from processes like MMBIR in genomes is poorly understood due to difficulty in directly identifying these events by whole genome sequencing (WGS). Here, by using our newly developed MMBSearch software, we directly detect such templated insertions (MMB-TIs) in human genomes and report substantial differences in frequency and complexity of MMB-TI events between normal and cancer cells. Through analysis of 71 cancer genomes from The Cancer Genome Atlas (TCGA), we observed that MMB-TIs readily accumulate de novo across several cancer types, with particularly high accumulation in some breast and lung cancers. By contrast, MMB-TIs appear only as germline variants in normal human fibroblast cells, and do not accumulate as de novo somatic mutations. Finally, we performed WGS on a lung adenocarcinoma patient case and confirmed MMB-TI-initiated chromosome fusions that disrupted potential tumor suppressors and induced chromothripsis-like CGRs. Based on our findings we propose that MMB-TIs represent a trigger for widespread genomic instability and tumor evolution.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421209 | PMC |
http://dx.doi.org/10.1093/nar/gkab685 | DOI Listing |
Mol Ther
September 2025
Be Biopharma, Cambridge, MA, 02139, USA. Electronic address:
Hemophilia B gene therapy treatments currently have not addressed the need for predictable, durable, active, and redosable factor IX (FIX). Unlike conventional gene therapy, engineered B Cell Medicines (BCMs) are durable, redosable, and titratable, and thus have the potential to address significant unmet needs in the Hemophilia B treatment paradigm. BE-101 is an autologous BCM comprised of expanded and differentiated B lymphocyte lineage cells genetically engineered ex vivo to secrete FIX-Padua.
View Article and Find Full Text PDFRSC Adv
August 2025
Key Laboratory of Engineering Plastics, Beijing National Laboratory for Molecular Science, Institute of Chemistry, Chinese Academy of Sciences Beijing 100190 China
Iminopyridine nickel catalysts are typically prone to facile chain transfer reactions, resulting in low molecular weight polyethylenes. In this study, a spatial proximity strategy was employed in 5-dibenzosuberyl-modified iminopyridine nickel catalysts to enhance ethylene polymerization. Using a template reaction between acetylpyridine and 5-dibenzosuberyl-functionalized aniline, a series of 2-(1-(2,6-bis(5-dibenzosuberyl)-4-(alkyl)phenylimino)ethyl)pyridine ligands were synthesized and subsequently reacted with (1,2-dimethoxyethane)NiBr to afford the corresponding nickel complexes.
View Article and Find Full Text PDFNat Biotechnol
September 2025
Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Base editors create precise genomic edits by directing nucleobase deamination or removal without inducing double-stranded DNA breaks. However, a vast chemical space of other DNA modifications remains to be explored for genome editing. Here we harness the bacterial antiphage toxin DarT2 to append ADP-ribosyl moieties to DNA, unlocking distinct editing outcomes in bacteria versus eukaryotes.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
September 2025
Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208.
Genome editing with CRISPR-Cas systems hold promise for treating a wide range of genetic disorders and cancers. However, efficient delivery of genome editors remains challenging due to the requirement for the simultaneous delivery or intracellular generation of Cas proteins, guide RNAs, and, in some applications, donor DNAs. Furthermore, the immunogenicity and toxicity of delivery vehicles can limit the safety and efficacy of genetic medicines.
View Article and Find Full Text PDFMethods Mol Biol
August 2025
Emeritus, Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, USA.
Many genomics specialists recognize that the massive genome rearrangements grouped under the term "chromoanagenesis" are a path to rapid evolutionary change by restructuring chromosomes, creating chimeric sequence combinations, and altering regulatory interactions leading to novel phenotypes. Less attention has been paid to the role of ubiquitous eukaryotic double-strand DNA break repair functions known as "alternative end-joining" (AltEJ) in generating additional DNA sequence innovation. A close look at some examples of chromoanagenesis rearrangements in the human germline and tumor cells illustrates how diverse these novel sequences can be.
View Article and Find Full Text PDF